Zealand Pharma treasury share notification
Analysis based on 6 articles · First reported Aug 24, 2026 · Last updated Aug 24, 2026
The announcement is a routine regulatory filing with no direct impact on Zealand Pharma's operations or financials. Market reaction is expected to be neutral, as treasury share holdings are a standard corporate governance matter.
On August 24, 2026, Zealand Pharma A/S issued a company announcement (No. 42/2026) pursuant to Section 31 of the Danish Capital Markets Act, disclosing its holding of treasury shares. As of August 21, 2026, the company held 3,597,842 treasury shares, representing 5.03% of its total share capital and voting rights. Under Section 85 of the Danish Companies Act, Zealand Pharma cannot exercise voting rights attached to these shares. The announcement is a routine regulatory disclosure and does not indicate any change in business operations or strategy.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard